The Technology Accelerator Challenge will focus on sickle cell disease, malaria and anemia. Ideally, the challenge will result in the creation of a platform technology that can both rapidly screen large global populations and serve as a therapeutic tool for individual patients.
Because a main goal of the challenge is to improve access to diagnostic tools and treatments in low-income areas, the ideal solution is portable and inexpensive, can be used to treat multiple diseases and adapts to each patient’s individual health and environment.
The winner of the challenge will receive up to $500,000, with five semifinalists receiving smaller awards. Additionally, the Bill & Melinda Gates Foundation will contribute grants of up to $500,000 and potential partnerships, consultations and other follow-on support for the competition’s winners and runners-up.
More articles on innovation:
Shriners Hospitals for Children, Georgia Tech team up for neuromuscular innovation
Johns Hopkins MBA program receives $25M to enhance healthcare innovation focus
AHA launches $100K innovation challenge to improve behavioral health
